BPC-157

Tissue & Wound Healing Accelerates repair of tendon, ligament, muscle, skin, bone, cornea (animal studies) . Joint & Tendon Recovery Knee pain relief: 91.6% of 12 subjects reported significant improvement after intra-articular Joe Rogan anecdote: resolution of tendonitis in ~2 weeks . Gut & GI Protection Stable, protective in ulcerative colitis, supports fistula healing and GI integrity . Neuroprotection & Inflammation Reduction Protects neurons post�TBI, counters anxiety, alcohol and benzodiazepine toxicity . Angiogenesis & Vascular Health Promotes blood vessel growth in injured tissue, improving healing outcomes

BPC?157 is a multi-targeted peptide with robust preclinical evidence supporting accelerated healing in soft tissues, muscular, gastrointestinal, and neurological injury, driven by vascular, growth factor, and cellular migratory pathways. While early human data and anecdotal reports are encouraging�especially for tendon, joint, and GI health�clinical evidence remains limited. Emerging use in longevity and sports medicine warrants cautious optimism, balanced by awareness of angiogenic risks, quality control variability, and regulatory non-approval. Tissue Regeneration & Growth Factor Upregulation Increases expression of growth hormone receptors in tendon fibroblasts by up to 7-fold, enhancing GHdriven cellular proliferation via JAK2/STAT pathways Pro?angiogenic & Vascular Protection Activates VEGFR2�Akt�eNOS signaling, enhancing angiogenesis in ischemic muscle peptides- Modulates nitric oxide pathways, supporting endothelial function and counteracting Cell Migration & Adhesion Pathways Stimulates FAK/paxillin phosphorylation, aiding cell migration and survival�critical in wound and tendon repair nti?inflammatory & Neuroprotective Effects Modulates inflammatory response, supports healing in tendon, ligament, muscle, bone, skin, GI tract, and the central nervous system Gut Integrity & Organ Protection Maintains gastric mucosa, supports healing in ulcerative colitis and fistulas, stabilizes GI tract barrier

Extremely well-tolerated in both human and animal models No known toxicity at therapeutic dosing levels Non-immunogenic and does not suppress natural healing processes Rare side effects (typically dose-dependent or from improper injection): Nausea Mild headache Temporary dizziness Injection site irritation Use caution in patients on anticoagulants or hypertensive medications, as BPC-157 may influence vascular healing and blood flow

BPC-157 10mg/5mL DOSING 10 units low dose | 15 units moderate dose | 20-25 units typical dose Start low, acclimate, titrate up based on how you feel